These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25176087)

  • 1. [Atorvastatin inhibits platelet aggregation and activation following carotid balloon injury in cholesterol-fed rabbits].
    Tong B; Lin Z; Xie L; Xu C
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1162-6. PubMed ID: 25176087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of neointimal hyperplasia in rats treated with atorvastatin after carotid artery injury may be mainly associated with down-regulation of survivin and Fas expression.
    Xu Y; Zhou S; Fang Z; Li X; Huang D; Liu Q; Zheng C
    Pharm Biol; 2014 Sep; 52(9):1196-203. PubMed ID: 25116077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of LDL-C combined with low levels of HDL-C further increase platelet activation in hypercholesterolemic patients.
    Chan LW; Luo XP; Ni HC; Shi HM; Liu L; Wen ZC; Gu XY; Qiao J; Li J
    Braz J Med Biol Res; 2015 Feb; 48(2):167-73. PubMed ID: 25466164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms.
    Moscardó A; Vallés J; Latorre A; Madrid I; Santos MT
    Thromb Res; 2013 Apr; 131(4):e154-9. PubMed ID: 23352311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin reduces serum leptin concentration in hypercholesterolemic rabbits.
    Zhao SP; Wu ZH
    Clin Chim Acta; 2005 Oct; 360(1-2):133-40. PubMed ID: 16014304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low flow enhances platelet activation after acute experimental arterial injury.
    Bassiouny HS; Song RH; Kocharyan H; Kins E; Glagov S
    J Vasc Surg; 1998 May; 27(5):910-8. PubMed ID: 9620144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Elisaf M; Goudevenos JA; Tselepis AD
    Platelets; 2005 Aug; 16(5):287-92. PubMed ID: 16011979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atorvastatin on tumor necrosis factor alpha serum concentration and mRNA expression of adipose in hypercholesterolemic rabbits.
    Zhao SP; Wu ZH; Wu J; Hong SC; Deng P
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):185-9. PubMed ID: 16044030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of atorvastatin on platelet function in patients with coronary artery disease.
    Tekten T; Ceyhan C; Ercan E; Onbasili AO; Turkoglu C
    Acta Cardiol; 2004 Jun; 59(3):311-5. PubMed ID: 15255464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway.
    Zhou G; Ge S; Liu D; Xu G; Zhang R; Yin Q; Zhu W; Chen J; Liu X
    Cardiology; 2010; 115(3):221-8. PubMed ID: 20234134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin delays murine platelet activation in vivo even in the absence of endothelial NO synthase.
    Ni R; Peleg T; Gross PL
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2609-15. PubMed ID: 22995523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of minocycline on carotid atherosclerotic plaques.
    Gao J; Gao X; Pan S
    Neurol Res; 2013 Oct; 35(8):844-50. PubMed ID: 23676309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Markers of inflammation and platelet aggregation in patients with non ST elevation acute coronary syndrome treated with atorvastatin or pravastatin].
    Pokrovskaia EV; Vaulin NA; Gratsianskiĭ NA; Averkov OV; Deev AD
    Kardiologiia; 2003; 43(1):7-18. PubMed ID: 12891281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of atorvastatin treatment on the hemorheologic and hemostatic parameters in chronic cerebrovascular patients].
    Szapáry L; Horváth B; Márton Z; Fehér G; Tóth K; Komoly S
    Orv Hetil; 2008 Jun; 149(24):1117-23. PubMed ID: 18539578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits.
    Li JQ; Zhao SP; Li QZ; Cai YC; Wu LR; Fang Y; Li P
    Clin Chim Acta; 2006 Aug; 370(1-2):57-62. PubMed ID: 16507303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
    Piorkowski M; Fischer S; Stellbaum C; Jaster M; Martus P; Morguet AJ; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2007 Mar; 49(10):1035-42. PubMed ID: 17349882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
    Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T
    Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits.
    Zhao SP; Wu ZH; Hong SC; Ye HJ; Wu J
    Clin Chim Acta; 2006 Mar; 365(1-2):119-24. PubMed ID: 16185675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of intensive statin use on the level of inflammation and platelet activation in stable angina after percutaneous coronary intervention: a clinical study.
    Li Q; Deng SB; Xia S; Du JL; She Q
    Med Clin (Barc); 2013 Jun; 140(12):532-6. PubMed ID: 23177313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model.
    Li M; Zhang Y; Ren H; Zhang Y; Zhu X
    Atherosclerosis; 2007 Oct; 194(2):348-56. PubMed ID: 17156785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.